-
公开(公告)号:EP1570080A1
公开(公告)日:2005-09-07
申请号:EP03786796.7
申请日:2003-11-14
CPC分类号: C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , C12Q2600/16
摘要: The present invention concerns prognostic markers associated with EGFR positive cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed tissue samples of EGFRexpressing cancer, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.